STOCK TITAN

Polomar Health Services issues $450K commission note

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Polomar Health Services, Inc. (PMHS) executed a $450,000 promissory note in favor of Island 40 Group, LLC, reflecting commissions due for services under a Sales Director and Distribution Agreement. Polomar Specialty Pharmacy, LLC, the company’s wholly owned subsidiary, is a guarantor and accepts all obligations under the note.

The note bears 10% per annum simple interest through December 31, 2026; thereafter, the rate is the prime interest rate published on the first day of each month in the Wall Street Journal Money Rates plus 4%. It matures and is payable in full on March 31, 2027, and may be prepaid at any time without penalty or premium. Bankruptcy or insolvency makes all amounts immediately due; for other events of default, the lender may declare them due. Payments apply first to fees, then accrued interest, then principal.

Filing Explained

In the executed note, Island 40 may transfer the debt without notice or Polomar’s consent; Polomar cannot assign its obligations without written consent and waives setoff, counterclaim, and defenses to payment.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Note principal $450,000 Promissory note reflecting commissions due to Island 40 Group, LLC.
Initial interest rate 10% per annum Simple interest through December 31, 2026.
Subsequent interest rate Wall Street Journal prime interest rate + 4% per annum The prime interest rate is published on the first day of each month; applies after December 31, 2026.
Maturity date March 31, 2027 The note is payable in full on this date.
simple interest financial
"10% per annum, simple interest through December 31, 2026"
Simple interest is a way of calculating interest where payments are based only on the original amount lent or invested, not on interest that accumulates over time. Think of it like getting a fixed tip each period on the initial bill rather than earning interest on the tip itself; it keeps returns predictable and makes it easy for investors and borrowers to compare total interest cost or income over a set term.
events of default financial
"The Note contains customary events of default"
Events of default are specific breaches or failures listed in a loan, bond, or credit agreement that give lenders the right to act, such as demanding immediate repayment, raising interest rates, or taking secured assets. They matter to investors because triggering one is like setting off a financial alarm: it raises the chance of foreclosure, restructuring, or bankruptcy and can sharply reduce the value of a company’s stock or bonds and increase borrowing costs.
setoff financial
"waived rights of setoff, counterclaim and defense to payment"
guarantor financial
"Polomar Specialty Pharmacy, LLC ... as a guarantor of the Note"
prime interest rate financial
"prime interest rate as published on the first day of each month"
The prime interest rate is the standard interest rate banks charge their most creditworthy customers and serves as the starting point for many consumer and business loans, like a store’s posted price from which discounts are given. It matters to investors because changes in that rate ripple through the economy: higher rates raise borrowing costs, can slow growth and squeeze company profits, while lower rates tend to boost spending, investment and asset prices.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did PMHS issue a $450,000 note?

The note reflects $450,000 in commissions due and owing to Island 40 Group, LLC for services provided under the Sales Director and Distribution Agreement.

What is the interest rate and maturity date for PMHS’s note?

The note carries 10% per annum simple interest through December 31, 2026, then the Wall Street Journal prime interest rate published on the first day of each month plus 4%; it matures March 31, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001265521 0001265521 2026-11-13 2026-11-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 13, 2026 (November 9, 2026)

 

 

 

POLOMAR HEALTH SERVICES, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   000-56555   86-1006313
(State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)

 

575 Lexington Avenue, Suite 17-143, New York, NY 10022

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (727) 425-7575

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01 – Entry Into a Material Definitive Agreement.

 

The information set forth under Item 2.03 of this Current Report on Form 8-K is incorporated by reference into this Item 1.01.

 

Item 2.03 - Creation of a Direct Financial Obligation or an Obligation.

 

Effective November 9, 2026, Polomar Health Services, Inc. (the “Company”) executed a Promissory Note and Loan Agreement (the “Note”) in favor of Island 40 Group, LLC (“I4G” or the “Lender”) in the principal amount of $450,000 reflecting the amount of commissions due and owing to I4G for services provided to the Company by I4G pursuant to the terms of a certain Sales Director and Distribution Agreement in effect between the Company and I4G. Polomar Specialty Pharmacy, LLC, a wholly owned subsidiary of the Company (the “Guarantor”), is also a party to the Note as a guarantor of the Note and accepts all obligations of the Company thereunder.

 

The Note bears interest at an initial rate of 10% per annum, simple interest through December 31, 2026, and thereafter at a rate equal to the prime interest rate as published on the first day of each month in the Wall Street Journal – Money Rates plus 4%. The Note shall mature and be payable in full on March 31, 2027.

 

The Company may prepay the Note in whole or in part at any time without penalty or premium. Payments are applied first to fees, then to accrued interest, then to principal.

 

The Note contains customary events of default. If a bankruptcy or insolvency event occurs, all amounts under the Note become due immediately and automatically. For any other event of default, the Lender may declare all amounts due.

 

The Lender may assign the Note to a third party without notice to or consent of the Company. The Company may not assign its obligations without the Lender’s written consent. The Company has waived rights of setoff, counterclaim and defense to payment.

 

This description is a summary only and is qualified in its entirety by the full text of the Note, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
10.1   Promissory Note and Loan Agreement Effective November 9, 2026, between Island 40 Group. LLC and Polomar Health Services, Inc.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  POLOMAR HEALTH SERVICES, INC.
     
Date: November 13, 2026 By: /s/ Terrence M. Tierney
  Name:  Terrence M. Tierney
  Title: Interim Chief Executive Officer

 

 

 

Filing Exhibits & Attachments

4 documents

Keep reading